Xu Q, Zhang Q, Xu P, Zhang T, Wu H, Zhang X
Front Immunol. 2025; 16:1541574.
PMID: 40061947
PMC: 11885256.
DOI: 10.3389/fimmu.2025.1541574.
Li Y, Guan X, Lan T, Zhang Z, Zhang Y, Jiang S
J Cereb Blood Flow Metab. 2025; :271678X251321641.
PMID: 39985210
PMC: 11846095.
DOI: 10.1177/0271678X251321641.
Giordano C, Carlomagno S, Falco M, Cantoni C, Vitale M, Caruana I
Front Immunol. 2025; 16:1481745.
PMID: 39958331
PMC: 11825780.
DOI: 10.3389/fimmu.2025.1481745.
Jost S, Reeves R
Curr Opin HIV AIDS. 2025; 20(2):109-116.
PMID: 39773904
PMC: 11802307.
DOI: 10.1097/COH.0000000000000909.
Shi J, Shen L, Xiao Y, Wan C, Wang B, Zhou P
Front Immunol. 2024; 15:1450782.
PMID: 39654884
PMC: 11626409.
DOI: 10.3389/fimmu.2024.1450782.
Nutrient transporter pattern in CD56 NK cells: CD16 (FcγRIIIA)-dependent modulation and association with memory NK cell functional profile.
De Federicis D, Capuano C, Ciuti D, Molfetta R, Galandrini R, Palmieri G
Front Immunol. 2024; 15:1477776.
PMID: 39606236
PMC: 11599182.
DOI: 10.3389/fimmu.2024.1477776.
Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers.
Thongsin N, Suwanpitak S, Augsornworawat P, Srisantitham J, Saiprayong K, Jenjaroenpun P
Stem Cell Res Ther. 2024; 15(1):418.
PMID: 39533434
PMC: 11559060.
DOI: 10.1186/s13287-024-04029-z.
A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies.
Xu Z, Song J, Zhang H, Wei Z, Wei D, Yang G
Sci Rep. 2024; 14(1):23995.
PMID: 39402093
PMC: 11473516.
DOI: 10.1038/s41598-024-74221-x.
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.
Sedloev D, Chen Q, Unglaub J, Schanda N, Hao Y, Besiridou E
J Hematol Oncol. 2024; 17(1):85.
PMID: 39285441
PMC: 11406742.
DOI: 10.1186/s13045-024-01604-y.
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.
Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P
J Exp Clin Cancer Res. 2024; 43(1):259.
PMID: 39261955
PMC: 11389238.
DOI: 10.1186/s13046-024-03173-x.
Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases.
Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R
Front Immunol. 2024; 15:1421346.
PMID: 39211042
PMC: 11358079.
DOI: 10.3389/fimmu.2024.1421346.
Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome.
Pu Q, Dai Y, Hu N, Tao Z, Shi P, Jiang N
Virol J. 2024; 21(1):179.
PMID: 39107822
PMC: 11304918.
DOI: 10.1186/s12985-024-02452-5.
The function of long non-coding RNA IFNG-AS1 in autoimmune diseases.
Zhao J, Gui Y, Wu W, Li X, Wang L, Wang H
Hum Cell. 2024; 37(5):1325-1335.
PMID: 39004663
DOI: 10.1007/s13577-024-01103-9.
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.
Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R
Front Transplant. 2024; 3:1353803.
PMID: 38993780
PMC: 11235242.
DOI: 10.3389/frtra.2024.1353803.
Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.
Bharti R, Calabrese D
Front Transplant. 2024; 3:1388393.
PMID: 38993763
PMC: 11235306.
DOI: 10.3389/frtra.2024.1388393.
Natural killer cell memory: challenges and opportunities for cancer immunotherapy.
Qu Y, Zeng A, Cheng Y, Li S
Cancer Biol Ther. 2024; 25(1):2376410.
PMID: 38987282
PMC: 11238922.
DOI: 10.1080/15384047.2024.2376410.
Diversity of group 1 innate lymphoid cells in human tissues.
Jaeger N, Ulezko Antonova A, Kreisel D, Roan F, Lantelme E, Ziegler S
Nat Immunol. 2024; 25(8):1460-1473.
PMID: 38956380
DOI: 10.1038/s41590-024-01885-y.
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.
Wu L, Park S, Jakobsson H, Shackleton M, Moller A
Cancers (Basel). 2024; 16(11).
PMID: 38893071
PMC: 11171058.
DOI: 10.3390/cancers16111950.
Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.
Nakazawa T, Morimoto T, Maeoka R, Yamada K, Matsuda R, Nakamura M
Int J Mol Sci. 2024; 25(11).
PMID: 38892084
PMC: 11173110.
DOI: 10.3390/ijms25115896.
Analysis of Immune Cell Subsets in Peripheral Blood from Patients with Engineered Stone Silica-Induced Lung Inflammation.
Jimenez-Gomez G, Campos-Caro A, Garcia-Nunez A, Gallardo-Garcia A, Molina-Hidalgo A, Leon-Jimenez A
Int J Mol Sci. 2024; 25(11).
PMID: 38891910
PMC: 11171478.
DOI: 10.3390/ijms25115722.